Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 GMP-Validated Adventitious Virus Testing By Next Generation Sequencing | Contract Pharma
White Papers / Tech Papers

GMP-Validated Adventitious Virus Testing By Next Generation Sequencing

Released By IDT Biologika

Safety, quality, and efficacy of biologics are the basis for approving and authorizing through state regulatory bodies. Safety is ensured among other activities by quality controls during the manufacturing process. This also includes testing for unwanted agents which pose a threat to human health. This safety control step is called Adventitious Agent Testing. Here, we specifically deal with viral contamination and name this topic Adventitious Virus Testing (AVT). This white paper provides you with required knowledge related to the involved regulatory authorities and scientific technologies and disciplines: Next Generation Sequencing (NGS), Bioinformatics and Computer System Validation (CSV). Before starting, let us take a look at the history of AVT, which was not a matter of course.

Download White Papers / Tech Papers Now

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters